Atea director granted options and RSUs
Atea Pharmaceuticals director Arthur S. Kirsch received new equity awards.
Rhea-AI Filing Summary
Atea Pharmaceuticals director Arthur S. Kirsch received new equity awards. He was granted stock options covering 37,700 shares of common stock at an exercise price of $4.36 per share. These options vest in twelve substantially equal monthly installments after June 18, 2026 and are fully vested by June 18, 2027, subject to his continued service.
Kirsch also received 26,700 restricted stock units, each representing a contingent right to one share of common stock. These RSUs vest in a single installment on the earlier of the next annual stockholder meeting after June 18, 2026 or June 18, 2027, conditioned on continued service through the vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 64,400 shares
Grant/Award
2 txns
Insider
KIRSCH ARTHUR S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 26,700 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 37,700 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 26,700 contracts (Direct);
Stock Option (Right to Buy) — 37,700 contracts (Direct)
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- F2. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
- F3. The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Key Figures
Stock options granted: 37,700 options
Option exercise price: $4.36 per share
Option expiration: June 17, 2036
+3 more
6 metrics
Stock options granted
37,700 options
Grant to Arthur S. Kirsch on June 18, 2026
Option exercise price
$4.36 per share
Exercise price of granted stock options
Option expiration
June 17, 2036
Expiration date of stock options
RSUs granted
26,700 RSUs
Grant to Arthur S. Kirsch on June 18, 2026
Option vesting period end
June 18, 2027
Options fully vested by this date if service continues
RSU vesting trigger window
Next annual meeting after June 18, 2026 or June 18, 2027
Single-installment RSU vesting condition
Key Terms
Restricted Stock Units, Stock Option (Right to Buy, exercise price, vest
4 terms
Restricted Stock Units financial
"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy financial
"security_title": "Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price": "4.3600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Atea Pharmaceuticals (AVIR) director Arthur S. Kirsch receive?
Arthur S. Kirsch received 37,700 stock options and 26,700 restricted stock units. The options have a $4.36 exercise price, while each RSU represents a right to one share of Atea Pharmaceuticals common stock, subject to vesting conditions.
How do Arthur S. Kirsch’s new stock options at Atea Pharmaceuticals (AVIR) vest?
The 37,700 stock options vest in twelve substantially equal monthly installments following June 18, 2026. They become fully vested on June 18, 2027, provided Kirsch continues serving as a director through each applicable vesting date.
When do Arthur S. Kirsch’s restricted stock units in Atea Pharmaceuticals (AVIR) vest?
The 26,700 RSUs vest in a single installment on the earlier of the next annual stockholder meeting after June 18, 2026, or June 18, 2027. Vesting requires Kirsch’s continued service through the applicable vesting date.
What does each restricted stock unit (RSU) represent for Atea Pharmaceuticals (AVIR)?
Each restricted stock unit represents a contingent right to receive one share of Atea Pharmaceuticals common stock. The RSUs only convert into shares if the specified vesting conditions, including continued service through the vesting date, are satisfied.
What is the exercise price and expiration date of Arthur S. Kirsch’s Atea (AVIR) stock options?
The stock options granted to Kirsch carry an exercise price of $4.36 per share and expire on June 17, 2036. He must exercise them before that expiration date, subject to vesting and his continued service conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
